With an estimated AMH value decline of 5.6%/year among non-cancer patients ≤ 40 years (17), the physiological decline in our population would have led to a median AMH value 3 years after diagnosis of 1.4 μg/L, which is far more elevated than the value observed (0.17 μg/L). The gene discussed is AMH; the disease is cancer.